UCSF and ShangPharma collaborate to accelerate research

Under a new partnership, ShangPharma Innovation Inc. (South San Francisco, Calif.) will fund preclinical research at the University of California San Francisco to validate drug targets and discover drug candidates, the university said. Neither partner would provide financial terms of their deal.

ShangPharma's affiliated CRO Shanghai ChemPartner Co. Ltd. (Shanghai, China) will also provide CRO services during the partnership. Both are affiliated with ShangPharma Corp. (Shanghai, China)...